Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury

Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury

(2009) Chiara Adembri et al.   CRITICAL CARE MEDICINE

Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic

(2009) Zheng Gang Zhang et al.   LANCET NEUROLOGY

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

(2009) Hannelore Ehrenreich et al.   STROKE

Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism

(2009) Xuan Xu et al.   SURGERY

Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system

(2008) Ye Xiong et al.   BRAIN RESEARCH

Carbamylated erythropoietin to treat neuronal injury: new development strategies

(2008) Paul A Lapchak   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice

(2008) Ye Xiong et al.   JOURNAL OF NEUROSURGERY

Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia

(2007) Y Wang et al.   BRITISH JOURNAL OF PHARMACOLOGY